文献速递脑血管病

缺血性卒中:血栓组织学成分能否揭示血栓来源?

Ischemic Stroke: What Does the Histological Composition Tell Us About the Origin of the Thrombus?
PubMed 文献 · Stroke · 2017-06-16

发现心源性栓塞血栓较非心源性栓塞血栓有更高的纤维蛋白/血小板比例(P=0.027)、更少的红细胞(P=0.005)和更多的白细胞(P=0.026),且隐源性卒中与心源性栓塞卒中的血栓组织学高度重叠。结论认为血栓组织学特征有助于区分心源性与非心源性栓塞,并支持多数隐源性卒中具有心源性栓塞病因的假说。

要点

  • 心源性栓塞血栓纤维蛋白/血小板比例更高、红细胞更少、白细胞更多。
  • 隐源性卒中与心源性栓塞卒中的血栓组织学特征高度重叠。
  • 免疫组化指标CD3、CD20、CD68/KiM1P在卒中亚型间无显著差异。

核心结论

  • 血栓组织学特征随卒中亚型显著变化,可能有助于区分心源性栓塞与非心源性栓塞卒中。
  • 研究支持多数隐源性卒中具有心源性栓塞病因的假说。

研究设计与样本

  • 对取出的血栓样本进行HE、Elastica van Gieson和普鲁士蓝染色,并采用免疫组化检测CD3、CD20和CD68/KiM1P。
  • 按TOAST分类将患者分为心源性栓塞(77例)、非心源性栓塞(46例)和隐源性(64例)卒中,比较血栓组织学特征。

主要发现

  • 心源性栓塞血栓较非心源性栓塞血栓有更高的纤维蛋白/血小板比例(P=0.027)。
  • 心源性栓塞血栓较非心源性栓塞血栓红细胞更少(P=0.005)。
  • 心源性栓塞血栓较非心源性栓塞血栓白细胞更多(P=0.026)。
  • 隐源性卒中与心源性栓塞卒中的血栓组织学特征高度重叠。
  • 免疫组化参数CD3、CD20和CD68/KiM1P在卒中亚型间无统计学显著差异。

临床怎么用

  • 血栓组织学分析可能辅助判断缺血性卒中的病因,尤其是区分心源性栓塞与非心源性栓塞。
  • 对于隐源性卒中,血栓组织学特征提示心源性栓塞可能,支持进一步寻找心源性病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The introduction of stent retrievers allows for a complete extraction and histological analysis of human thrombi. Ischemic stroke is a major health issue, and differentiation of underlying causes is highly relevant to prevent recurrent stroke. Therefore, histopathologic analysis of the embolic clots after removal may provide valuable information about underlying pathologies. This study analyzes histological clot composition and aims to identify specific patterns that might help to distinguish causes of ischemic stroke. METHODS: Patients with occlusion of the carotid-T or middle cerebral artery who underwent thrombectomy at our university medical center between December 2013 and February 2016 were included. Samples were histologically analyzed (hematoxylin and eosin, Elastica van Gieson, and Prussian blue), additionally immunohistochemistry for CD3, CD20, and CD68/KiM1P was performed. These data, along with additional clinical and interventional parameters, were compared for different stroke subtypes, as defined by the TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification. RESULTS: One hundred eighty-seven patients were included, of these, in 77 patients, cardioembolic; in 46 patients, noncardioembolic; and in 64 patients, cryptogenic pathogenesis was determined. Cardioembolic thrombi had higher proportions of fibrin/platelets (P=0.027), less erythrocytes (P=0.005), and more leucocytes (P=0.026) than noncardioembolic thrombi. We observed a strong overlap of cryptogenic strokes and cardioembolic strokes concerning thrombus histology. The immunohistochemical parameters CD3, CD20, and CD68/KiM1P showed no statistically noticeable differences between stroke subtypes. CONCLUSIONS: Histological thrombus features vary significantly according to the underlying cause and may help to differentiate between cardioembolic and noncardioembolic stroke. In addition, our study supports the hypothesis that most cryptogenic strokes have a cardioembolic cause.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Sporns PB, Hanning U, Schwindt W, et al. Ischemic Stroke: What Does the Histological Composition Tell Us About the Origin of the Thrombus? Stroke. 2017. PMID: 28626055. doi:10.1161/STROKEAHA.117.016590

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。